Clinical Trial Detail

NCT ID NCT02107755
Title Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ohio State University Comprehensive Cancer Center
Indications

melanoma

Therapies

Ipilimumab

Age Groups: adult

No variant requirements are available.